Pfizer Inc. logo


Pfizer Inc.


Earnings Summary

Net Profits
Net Profit Margins
PE Ratio



Pfizer Inc.’s revenue jumped 46.19% since last year same period to $27742Mn in the Q2 2022. On a quarterly growth basis, Pfizer Inc. has generated 8.11% jump in its revenue since last 3-months.

Net Profits:

Pfizer Inc.’s net profit jumped 78.07% since last year same period to $9906Mn in the Q2 2022. On a quarterly growth basis, Pfizer Inc. has generated 25.97% jump in its net profits since last 3-months.

Net Profit Margins:

Pfizer Inc.’s net profit margin jumped 21.81% since last year same period to 35.71% in the Q2 2022. On a quarterly growth basis, Pfizer Inc. has generated 16.52% jump in its net profit margins since last 3-months.

PE Ratio:

Pfizer Inc.’s price-to-earnings ratio after this Q2 2022 earnings stands at 9.62.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Pfizer Inc. post its latest quarter earnings

EPS Estimate Current Quarter
EPS Estimate Current Year


EPS Estimate Current Quarter:

Pfizer Inc.’s earning per share (EPS) estimates for the current quarter stand at 1.84 - a 3.37% jump from last quarter’s estimates.

EPS Estimate Current Year:

Pfizer Inc.’s earning per share (EPS) estimates for the current year stand at 1.84.

Key Ratios

Key ratios of the Pfizer Inc. post its Q2 2022 earnings

Earning Per Share (EPS)
Return on Assets (ROA)
Return on Equity (ROE)
Dividend Per Share (DPS)


Earning Per Share (EPS):

Pfizer Inc.’s earning per share (EPS) jumped 90.65% since last year same period to 2.04 in the Q2 2022. This indicates that the Pfizer Inc. has generated 90.65% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Pfizer Inc.’s return on assets (ROA) stands at 0.13.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Pfizer Inc.’s return on equity (ROE) stands at 0.37.

Dividend Per Share (DPS):

Pfizer Inc. declared 1.58 dividend per share during the earnings announcement for Q2 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %

Company Information

“Pfizer Inc., founded in 1849 by Charles Pfizer and Charles F. Erhart, is an American Biotechnology and Pharmaceutical giant. It is currently headquartered in New York City, United States with worldwide operations and distributions. To ensure that the medicinal and vaccine requirements of every patient and individual are met, Pfizer has been adopting a rigorous and scientific approach towards its supply chain. They now have a network of 58 manufacturing sites around the world under Pfizer Global Supply (PGS). To further expand its operations in the research and pharmaceutical sphere, it entered various merger and acquisitions deals with other players including Wyeth, Pharmacia, Warner-Lambert, Innopharma, etc. Its primary focus areas include internal medicine, rare diseases, vaccines, inflammation, immunology, oncology, and anti-infectives. They have major R&D platforms in the fields of gene therapy, precision medicine, biosimilars, medicinal sciences, and maternal immunizations. Pfizer Is traded under the ticker symbol of PFE. The financials of Pfizer are as follows: While Pfizer clocked a revenue of $41.908 billion for 2020, its net income amounted to $6985 million for the same period. Pfizer has made significant contributions in the fight against Covid-19 and has been successful in the early development of the Pfizer-BioNTech Vocid-19 vaccine. In 2020, Pfizer achieved the Top Employer Certification for the 5th year in the UK. Going by the revenue, Pfizer is the 4th largest pharmaceutical company globally and the 3rd largest in terms of market capitalization. It is currently traded in NYSE and other indices, including S&P 100, S&P 500, and Russell 1000 Index. Currently Pfizer Inc. has a market cap of $300.01 Billion. It has a P.E ratio of 11.88. The shares of Pfizer Inc. are trading at $51.78. ” .

Pfizer Inc.
New York, New York, US
Health Technology
Albert Bourla